Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients
Open Access
- 5 February 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 27 (6), 1391-1393
- https://doi.org/10.1038/leu.2013.34
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Secondary Primary Malignancies in Multiple Myeloma: An Old Nemesis RevisitedAdvances in Hematology, 2012
- Lenalidomide after Stem-Cell Transplantation for Multiple MyelomaThe New England Journal of Medicine, 2012
- Second malignancies after multiple myeloma: from 1960s to 2010sBlood, 2012
- Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)Blood, 2011
- Prevalence of Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 2006
- Cancer Survivorship—Genetic Susceptibility and Second Primary Cancers: Research Strategies and RecommendationsJNCI Journal of the National Cancer Institute, 2006
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 2002
- Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myelomaBritish Journal of Haematology, 1996
- The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute LeukemiaThe New England Journal of Medicine, 1979
- Monoclonal gammopathy of undetermined significance: Natural history in 241 casesAmerican Journal Of Medicine, 1978